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Abstract: Microbial transformation of imbricatolic acid (1) by Aspergillus niger afforded 
1α-hydroxyimbricatolic acid (2), while transformation with Rhizopus nigricans yielded 15-
hydroxy-8,17-epoxylabdan-19-oic acid (3). When the diterpene 1 was added to a 
Cunninghamella echinulata culture, the main products were the microbial metabolites 
mycophenolic acid (4) and its 3-hydroxy derivative 5. All the structures were elucidated by 
spectroscopic methods. The cytotoxicity of these compounds towards human lung 
fibroblasts and AGS cells was assessed. While 4 and 5 showed low cytotoxicity, with IC50 
values > 1000 µM against AGS cells and fibroblasts, 1α-hydroxyimbricatolic acid (2) 
presented moderate toxicity towards these targets, with IC50 values of 307 and 631 µM, 
respectively. The structure of 2 is presented for the first time. 
 
Keywords: Aspergillus niger, Rhizopus nigricans, imbricatolic acid, biotransformation, 
diterpene, Cunninghamella echinulata, mycophenolic acid. 
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Introduction 
 
The diterpene imbricatolic acid (1) is one of the main constituents of the resin from the large tree 
Araucaria araucana (Mol.) Koch. The resin, as well as imbricatolic acid, have been recently shown to 
display gastroprotective effects in induced gastric lesion models in animals [1, 2]. The gastroprotective 
effect of several semisynthetic derivatives of imbricatolic acid was assessed, but so far none of them 
contained hydroxy functions in the A ring.  
Recent studies have reported the successful use of microorganisms for bioconversion of diterpenes. 
They include the biotransformation of stemodine by Rhizopus oryzae [3], the transformation of 
isosteviol by Aspergillus niger, Glomerella cingulata and Mortierella elongata [4], transformation of 
baccatin and 1β-hydroxybaccatin I with Aspergillus niger [5], microbial transformation of a pimarane 
derivative with Gibberella fujikuroi [6], of dehydroabietanol and teideadiol by Mucor plumbeus [7], 
stemodin and several Stemodia diterpenes with Aspergillus niger [8], Mucor plumbeus and Whetzelinia 
sclerotiorum [9]. 
The aim of the present work was to obtain new hydroxylated derivatives of imbricatolic acid by 
means of microbial transformation using Aspergillus niger, Cunninghamella echinulata and Rhizopus 
nigricans.  
 
Results and Discussion 
 
Microbial transformation of imbricatolic acid (1) by Aspergillus niger afforded a main compound, 
identified as 1α-hydroxyimbricatolic acid (2), while Rhizopus nigricans transformed imbricatolic acid 
to the epoxy derivative 3. From the Cunninghamella echinulata culture, the main compounds isolated 
were microbial metabolites, identified as mycophenolic acid (4) and its 3-hydroxy derivative 5 (Figure 
1). The structures of the known compounds were determined by 1D- and 2D-NMR techniques and 
confirmed by comparing the physical and spectroscopic/spectrometric data with those from the 
literature (NMR and MS).  
 
Figure 1. Structures of compounds 1-5. 
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The molecular formula of 2 proved to be C20H34O4 from HREIMS, DEPT and 13C-NMR data. The 
1H-NMR spectrum of compound 2 was close to that of 1, differing mainly by the presence of a broad 
singlet at δH 3.85 indicating a OH group, instead of a methylene group in the A ring. In the 13C-NMR 
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spectrum of 2, eight methylene sp3 C atoms and an oxygenated methine (δC 71.20 d) were observed, 
instead of the nine methylene sp3 C atoms seen for imbricatolic acid. The position of the hydroxy 
function followed from the signal multiplicity and the HMBC correlations. Clear correlations between 
the H signal at δ 3.85 and C-5 (δC 48.55) and C-3 (δC 30.70) helped position the OH group at C-1. The 
H-20 methyl group at δH 0.59 also presented a clear HMBC correlation with the C at δ 71.20, 
supporting the proposed structure. The stereochemistry of the OH function was deduced from the 
coupling constants which are about 7.7 Hz for the β-hydroxy function while the α-isomer signal 
appeared as a broad singlet with very small coupling constants (< 1 Hz) [7, 10]. The NMR spectral 
data of compound 2 are summarized in the Table 1.  
 
Table 1. 1H- and 13C-NMR data of compound 2 (400 and 100 MHz, respectively, CDCl3). 
δH (J in Hz)                    δC, mult. Position 
H C 
1 3.85, br s 71.20, CH 
2 1.60, 2.21, m 27.50, CH2 
3 1.94, 1.56, m 30.70, CH2 
4 - 44.00, qC 
5 1.82, m 48.55, CH 
6 1.87-2.00, m 25.81, CH2 
7 1.89, 2.36, m 38.39, CH2  
8 - 148.62, qC 
9 2.21, m 48.34, CH 
10 - 44.00, qC 
11 1.50, 1.31, m 19.58, CH2 
12 1.15, 1.37, m 35.18, CH2 
13 1.62, m 29.14, CH 
14 1.70, 1.29, m 38.81, CH2 
15 3.66, 3.72, m 61.13, CH2 
16 0.88, d (6.6) 20.55, CH3 
17 4.53 s, 4.86 s 106.96, CH2 
18 1.25, s 28.71, CH3 
19 - 183.41, qC 
20 0.59, s 13.24, CH3 
 
Among the several recently reported diterpene biotransformations by A. niger [9, 11, 12], only in 
the bioconversion of isoesteviol, in which the 1α,7α-dihydroxy derivative is obtained, was the 1α 
position hydroxylated [13]. Related compounds with an additional OH function include 3,15-
dihydroxy-8(17)-labden-19-oic acid from Juniperus thurifera [14, 15], the 6,15-dihydroxyderivative 
from Viburnum suspensum [16] and 7α-hydroxy-8(17)labdene-15,18-dioic acid from Haplopappus 
pulchellus [17]. A 7-β-hydroxy labdane derivative was described from Baccharis pedunculata [18] 
while other products were obtained from Eupatorium salvia [19]. Labdane derivatives with a 6-
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hydroxy function were isolated from Viburnum suspensum [16] while 3-hydroxy labdanes were 
obtained from Haplopappus chrysanthemifolius [20]. Beauveria bassiana ATCC 7159 was able to 
hydroxylate the stemodane and stemarane diterpenes stemodin and stemodinone, isolated from the 
Jamaican plant Stemodia maritima. The microorganisms yielded C-18 hydroxylated products of 
stemodin and stemodinone while stemarin was oxidized at C-1 to the corresponding β-configured 
alcohol as well as to the C-19 carboxylic acid [21]. Cunninghamella echinulata var. elegans 
hydroxylated stemodin to its 7α-hydroxy, 7β-hydroxy and 3β-hydroxy derivatives. Using this 
microorganism, stemarin was hydroxylated at the 6α position with oxidation of the C-19 methyl group 
to a carboxylic acid. Phanerochaete chrysosporium was able to hydroxylate stemodin to its 7 β-
hydroxy as well as to the 3β-hydroxy and 11β-hydroxyderivatives and to hydroxylate stemodinone at 
C-19 [22]. These reports clearly illustrate the potential of microbial transformations to give selective 
oxidation products of diterpenoids.  
Mycophenolic acid (4) has been reported as an immunosuppressive compound [23] and to present 
promising activity in the treatment of immune-mediated renal diseases [24]. The immunosuppressive 
and antitumor activities of mycophenolic acid have been recently reviewed [25]. Other biological 
activities reported for this compound include antifungal, antibacterial and antiviral effects [26]. To the 
best of our knowledge, this is the first report of mycophenolic acid production by Cunninghamella 
species. Until now the compound was reported only from cultures of Byssochlamys nivea [27] and 
mainly from several Penicillium species, such as P. brevi-compactum [28], P. roqueforti [29], P. 
roqueforti var. carneum [30], P. bialowiezense, P. chrysogenum [31], P. raciborkii [27], P. 
stoloniferum and other Penicillium spp. [32]. On the other hand, 3-hydroxymycophenolic acid (5) was 
obtained as a microbial transformation product of mycophenolic acid [33, 34]. The total synthesis of 
mycophenolic acid has been reported [26]. 
Compound 2 presented moderate toxicity towards AGS cells and fibroblasts, with IC50 values of 
307 and 631 µM, respectively. Compound 1 presented cytotoxicity IC50 values of 134 and 280 µM 
towards AGS cells and fibroblasts, respectively [2]. The cytotoxicity of the derivative 3 (IC50 values) 
was previously reported as 288 and 305 µM towards AGS cells and fibroblasts, respectively [2]. 
Mycophenolic acid (4) and its derivative 5 showed low cytotoxicity with IC50 values > 1000 µM 
against AGS cells and fibroblasts. 
 
Experimental 
 
General  
 
Melting points were determined on a Koffler hot stage apparatus (Electrothermal 9100) and are 
uncorrected. Optical rotations were obtained on a Jasco DIP 370 polarimeter, and IR spectra were 
recorded on a Nicolet Nexus FT-IR instrument. The NMR spectra were recorded in CDCl3 on a Bruker 
Avance 400 NMR spectrometer at 400 MHz for 1H and 100 MHz for 13C, respectively. MS spectra 
were measured in a Varian unit at 70 eV. Silica gel 60 (Merck, 63-200 µm particle size) was used for 
column chromatography; precoated Silica gel plates (Merck, Kieselgel 60 F254, 0.25 mm) were used 
for TLC analysis. TLC spots were visualized by spraying the chromatograms with p-anisaldehyde-
ethanol-acetic acid-H2SO4 (2:170:20:10 v/v) and heating at 110 °C for 3 min. Imbricatolic acid (15-
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hydroxylabd-8(17)-en-19-oic acid, 1) was isolated from Araucaria araucana resin as previously 
reported and recrystallized as colorless crystals, mp 102-105 °C [1, 2]. 
 
Microorganisms 
 
The microorganisms used were either from the American Type Culture Collection (ATCC): 
Aspergillus niger ATCC 16404, Cunninghamella echinulata ATCC 8688a or the Micoteca de la 
Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina: Rhizopus 
nigricans UBA 6. 
 
Screening scale experiments  
 
Liquid Czapek medium (30 mL) held in 125 mL Erlenmeyer flasks was innoculated with a spore 
suspension in a first fermentation stage. Stage I cultures were incubated on a rotatory shaker at 250 
rpm and 28 ºC ± 2 °C for 48 h. The second fermentation stage was initiated by transferring the 
inoculum from the Stage I culture in a final volume of 10%. After 48 h incubation, substrate 1 (10 mg) 
dissolved in dimethylformamide was added in each flask. Samples (5 mL of incubation media) were 
withdrawn every 12, 24 and 48 h, partitioned with EtOAc (2 mL) and analyzed by TLC. Three 
experiments with two repetitions each were carried out for every fungal agent. Blank assays without 
substrate and without fungi were carried out. 
 
Preparative scale experiments and product isolation  
 
Aspergillus niger ATCC 16404 culture.  
 
     First fermentation stage was performed as described for the screening experiments. In Stage II the 
substrate at 200 mg L-1 was added to each of ten 5 L-Erlenmeyer flasks containing 48 h old culture (1 
L). After 15 days, the culture was separated into culture medium and mycelium by filtration. 
Extraction of the culture filtrates with EtOAc (3 x 500 mL each) after acidification with HCl to pH 5, 
afforded 800 mg of EtOAc-solubles. Chromatography of the crude extract on silica gel (100 g, column 
length 42 cm, internal diameter 1.8 cm) with a CHCl3-acetone gradient afforded 56 fractions, pooled 
into nine groups according to the TLC patterns. From the fraction pools 1-2, some 85 mg imbricatolic 
acid (1) was recovered, while the pooled fraction 6 (70 mg), yielded 30 mg of 1-α,15-dihydroxylabd-
8(17)-en-19-oic acid (1-α-hydroxyimbricatolic acid (2) as colorless crystals; mp 179-181 °C; [α] 20D  + 
56.77° (c = 0.303, MeOH); IR (KBr) νmax 3441, 2942, 2928, 1687, 1461, 1197, 1060, 1029, 895 cm-1; 
for NMR data, see Table 1; EIMS m/z 338 [M]+ (17), 320 (46), 275 (74), 234 (48), 219 (52), 201 (29), 
189 (38), 182 (41), 173 (100), 169 (63), 159 (39), 137 (73), 133 (84), 123 (86), 197 (87), 95 (95), 81 
(94), 55 (96); HREIMS m/z 338.485 (calcd. for C20H34O4, 338.485). 
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Cunninghamella echinulata ATCC 8688a culture.  
 
First fermentation stage was performed as described for the screening experiments. In Stage II the 
substrate (200 mg L-1) was added to each of 12 5 L-Erlenmeyer flasks containing 48 h culture (1 L). 
After 14 days, the culture was separated into culture medium and mycelium by filtration. Extraction of 
the culture filtrates with EtOAc (3 x 500 mL each), after acidification with HCl to pH 5, afforded 4.9 g 
of EtOAc-solubles. Chromatography of the crude extract on 400 g silica gel with a petroleum ether 
(PE)-ethyl acetate (EtOAc) gradient afforded some 65 fractions of ca. 70 mL each. Fractions 1-9 
contained no compounds of interest and were discarded. Fractions 10-18 yielded some 80 mg of 
imbricatolic acid (1), while fractions 26-28 afforded 500 mg of mycophenolic acid (4) [26] and the 
pooled fractions 29-46 contained 10.5 mg of 3-hydroxymycophenolic acid (5) [33, 34]. The 
spectroscopic of the isolated compounds were in agreement with the structures and with published data. 
    
Rhizopus nigricans UBA6 culture.  
 
First fermentation stage was performed as was described for the screening experiments. In Stage II 
the substrate (200 mg L-1) was added to each ten 5 L-Erlenmeyer flasks containing 48 h culture (1 L). 
After 5 days, the culture was separated into culture medium and mycelium by filtration. Extraction of 
the culture filtrates with EtOAc (3 x 500 mL) after acidification with HCl to pH 5, afforded 680 mg of 
EtOAc-solubles. This EtOAc extract was chromatographed on 40 g silica gel with a PE, PE-EtOAc, 
EtOAc and EtOAc-MeOH gradient. Fractions 1 (PE, 100 mL), 2-3 (PE-EtOAc 9:1, 200 mL) and 4 
(PE-EtOAc 8:2, 100 mL) did not contain any compounds of interest and were discarded. Fractions 5 
and 6 (PE-EtOAc 7:3 and 1:1, 100 mL each) contained 120 mg of imbricatolic acid (1). Fractions 7-8 
eluted with EtOAc (200 mL) and 9-10 (EtOAc-MeOH 9:1, 200 mL) afforded a mixture of imbricatolic 
acid (1) and a second, more polar compound which gave a red-violet spot with anisaldehyde-sulphuric 
acid reagent. Preparative TLC of the combined fractions 7-10 (silica gel, PE-EtOAc 1:1) afforded 60 
mg of imbricatolic acid (1) and 30 mg of 15-hydroxy-8,17-epoxylabdan-19-oic acid (3) [2].  
 
MRC-5 cell culture 
 
The cytotoxic effect of the assayed compounds, expressed as cell viability, was assessed on a 
permanent fibroblast cell line derived from human lung (MRC-5) (ATCC CCL-171). MRC-5 
fibroblasts were grown as monolayers in minimum essential Eagle medium (MEM), with Earle's salts, 
L-glutamine (2 mM) and sodium bicarbonate (2.2 gL-1), supplemented with 10% (v/v) heat-inactivated 
fetal bovine serum (FBS), penicillin (100 IUmL-1) and streptomycin (100 µgmL-1) in a humidified 
incubator with 5% CO2 in air at 37 °C. Cell passage was maintained between 10 and 16. The medium 
was changed every 2 days.  
 
AGS cell culture  
 
     The cytotoxic effect of the assayed compounds, expressed as cell viability, was assessed on a 
permanent human gastric epithelial cell line (AGS) (ATCC CRL-1739). The AGS cells were grown as 
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monolayers in Ham F-12 medium containing L-glutamine (1 mM) and sodium bicarbonate (1.5 gL-1), 
supplemented with 10% (v/v) heat-inactivated FBS, penicillin (100 IUmL-1) and streptomycin (100 
µgmL-1) in a humidified incubator with 5% CO2 in air at 37 °C. The cell passage was maintained 
between 42 and 48. The medium was changed every 2 days. 
 
Cytotoxicity assay  
 
Confluent cultures of MRC-5 as well as AGS cells were treated with medium containing the 
diterpene derivatives at concentrations ranging from 0 up to 1000 µM. The products were first 
dissolved in DMSO and then in the corresponding culture medium supplemented with 2% FBS. The 
final content of DMSO in the test medium and controls was 1% (v/v). Cells were exposed for 24 h to 
the test medium with or without the compound (control). Each concentration was tested in 
quadruplicate together with the control and repeated three times in separate experiments. At the end of 
the incubation, the neutral red uptake (NR) assay was carried out [35]. To calculate the IC50 values 
(concentration that produces a 50% inhibitory effect on the evaluated parameter) the results were 
transformed to percentage of controls and the IC50 values were graphically obtained from the dose-
response curves. 
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